Zacks Investment Management Takes Position in Addus HomeCare Co. (NASDAQ:ADUS)

Zacks Investment Management bought a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 9,121 shares of the company's stock, valued at approximately $1,143,000. Zacks Investment Management owned approximately 0.05% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. Smartleaf Asset Management LLC increased its stake in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in Addus HomeCare in the 4th quarter worth approximately $77,000. Harvest Fund Management Co. Ltd bought a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $86,000. Finally, KBC Group NV increased its position in shares of Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock valued at $102,000 after purchasing an additional 268 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on ADUS shares. Macquarie reissued an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research report on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday. Stephens restated an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Oppenheimer increased their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Finally, StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $139.00.

Addus HomeCare Stock Up 0.6 %

Shares of ADUS traded up $0.57 during trading hours on Thursday, reaching $99.43. 32,023 shares of the company traded hands, compared to its average volume of 163,167. The stock has a market capitalization of $1.81 billion, a PE ratio of 22.75, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The stock has a fifty day simple moving average of $98.47 and a 200 day simple moving average of $116.52.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million during the quarter, compared to analysts' expectations of $291.04 million. Research analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.